Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Treat early Treat effectively

Summary by Multiple Sclerosis Research Blog
It was said that to control atrophy you need T and B cell inhibition and that was based on the effect of alemtuzumab on atrophy verses the effect on atrophy of cladribine and ocrelizumab, which are…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

Multiple Sclerosis Research BlogMultiple Sclerosis Research Blog

Treat early Treat effectively

It was said that to control atrophy you need T and B cell inhibition and that was based on the effect of alemtuzumab on atrophy verses the effect on atrophy of cladribine and ocrelizumab, which are…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Multiple Sclerosis Research Blog broke the news in on Saturday, April 19, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal